Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo

Completed

• Conditions: Tandplakvorming; de novo plaque formation

• Registration Number: NL-OMON35463
• Lead Sponsor: ACTA dental research B.V.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

• >= 18 years • Systemically healthy • minimum of 5 teeth per quadrant • absence of oral lesions • not participate in other clinical care study • Overnight plaque assessment of Modified Quigley & Hein index score >=2 • No orthodontic appliances (except for retention lingual wire) • No removable (partial) dentures • No prosthetics crowns • No overhanging margins • Signed written-informed consent

Exclusion Criteria

• The use of antibiotics during the last 6 months • Dutch Periodontal Screening Index (DPSI) >=3+ • Use of medication possibly influencing normal gingival health • Pregnancy • Smoking • The use of electric toothbrush

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome variable is the Modified Quigley & Hein index</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome variable is:<br /><br>• The Bleeding on marginal probing (BOMP) index.<br /><br>• Results from the VAS questionnaire to evaluate the subject*s attitude towards<br /><br>the used products.<br /><br>• Microbiological analysis to monitor shifts in the composition of the<br /><br>microbiota</p><br>